Klotho Deficiency and the Cardiomyopathy of Advanced CKD.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Effects of chronic kidney disease on cognitive function and α-klotho expression in hippocampus.Translational andrology and urology · 2022
   Article
2. Left atrial deformation as a potent predictor for paroxysmal atrial fibrillation in patients with end-stage renal disease.The international journal of cardiovascular imaging · 2018
   Article
3. Cardiovascular-renal complications and the possible role of plasminogen activator inhibitor: a review.Clinical kidney journal · 2016
   Article
4. The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy.Current opinion in nephrology and hypertension · 2016
   Review

Corrections and comments

• Comment on
  Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.2015

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as